Cefadroxil 500mg + Clavulanate 125mg Tablet in PCD pharma franchise in Hyderabad

Cefadroxil 500mg + Clavulanate 125mg Tablet in pharmaceutical manufacturing company in Mumbai

Cefadroxil 500mg + Clavulanate 125mg Tablet in antibiotic pharma franchise in Pune

Cefadroxil 500mg + Clavulanate 125mg Tablet in pharma suppliers in Delhi

Cefadroxil 500mg + Clavulanate 125mg Tablet in pharma export companies in Kolkata
Droxifix CV Tablet in antibacterial pharma franchise opportunities in Bengaluru

Home/Products /cefadroxil-500mg-potassium-clavulanate-125mg-tablets

About the Product

Description


Droxifix CV Tablet is a combination of Cefadroxil 500mg, a first-generation cephalosporin antibiotic, and Potassium Clavulanate 125mg, a beta-lactamase inhibitor. Cefadroxil works by disrupting bacterial cell wall synthesis, effectively killing susceptible bacteria. Clavulanate enhances the efficacy of Cefadroxil by inhibiting beta-lactamase enzymes produced by resistant bacteria, thus extending the antibacterial spectrum of the formulation. This synergy provides effective treatment against both gram-positive and certain gram-negative organisms, including resistant strains.

The most commonly observed side effects include nausea, diarrhea, abdominal discomfort, and skin rash. Rare but serious reactions may involve hypersensitivity, liver enzyme elevations, or antibiotic-associated colitis. Most adverse effects are mild and self-limiting.

Droxifix CV Tablet is indicated for the treatment of respiratory tract infections, tonsillitis, pharyngitis, skin and soft tissue infections, urinary tract infections, and ENT infections caused by beta-lactamase-producing pathogens. It is especially useful in cases where resistance to cephalosporins alone is a concern.

Use this medicine only under medical supervision. Complete the full prescribed course to prevent antimicrobial resistance. Caution is advised in patients with known allergies to penicillins or cephalosporins. Dose adjustment may be necessary in patients with renal impairment.

Store in a cool, dry place below 25°C. Protect from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Droxifix CV Tablet (Cefadroxil 500mg + Potassium Clavulanate 125mg) in the PCD pharma franchise market?

Droxifix CV Tablet has strong demand in the antibiotic and anti-infective segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on general medicine and infectious disease portfolios.

Why should medical distributors include Droxifix CV Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for management of respiratory tract infections, throat infections, urinary tract infections, skin infections, soft tissue infections, and other bacterial infections. Cefadroxil 500mg is a cephalosporin antibiotic effective against a wide range of bacterial infections Potassium Clavulanate 125mg helps enhance antibiotic effectiveness by reducing bacterial resistance Together, they provide broad-spectrum antibacterial coverage, strengthening a reliable anti-infective portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Droxifix CV Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Droxifix CV Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Droxifix CV Tablet?

Wholesalers and medical agencies benefit from strong physician prescriptions, high demand in anti-infective therapy, fast retail movement, reliable supply chain support, and good margins in antibiotic medicines.

How can I become a distributor or franchise partner for Droxifix CV Tablet?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.